Cabergoline (CAS 81409-90-7): A Comprehensive Pharmaceutical Overview
Discover the therapeutic power of Cabergoline for hyperprolactinemic disorders and pituitary adenomas.
Get a Quote & SampleProduct Core Value
Cabergoline
Cabergoline is a highly effective pharmaceutical chemical renowned for its potent dopamine D2 receptor agonist activity. Its primary application lies in treating hyperprolactinemic disorders, including those stemming from pituitary adenomas, thereby addressing issues like infertility and irregular menstrual cycles.
- Expertly formulated for treating hyperprolactinemia, this compound aids in restoring hormonal balance.
- Key for managing pituitary adenoma conditions, offering a targeted approach to hormonal regulation.
- A crucial component for fertility treatments, helping to resolve issues arising from hormonal imbalances.
- Supports menstrual cycle regulation by addressing underlying hormonal causes of irregularity.
Key Advantages
Hormonal Regulation
Utilize Cabergoline for precise treatment of hyperprolactinemia, ensuring optimal hormonal levels.
Therapeutic Efficacy
Experience the efficacy of this dopamine agonist in addressing complex endocrine conditions like pituitary adenomas.
Quality Assurance
Source high-purity Cabergoline, adhering to stringent pharmaceutical standards for reliable application.
Key Applications
Endocrine Health Management
Crucial for managing conditions associated with elevated prolactin, contributing to better endocrine health.
Reproductive Health Support
A vital element in reproductive health, aiding in fertility treatments and resolving menstrual irregularities.
Pharmaceutical Manufacturing
Serves as a key pharmaceutical chemical intermediate in the synthesis of vital medications.
Medical Research
An essential compound for ongoing research into hormonal disorders and dopamine receptor activity.